James Tyree Increases Stake in GNLX
James Tyree purchased 31,566 shares of GNLX on June 16, 2026.
Key Points
- James Tyree bought 31,566 shares of GNLX on June 16, 2026, with the stock priced at around $2.97.
- GNLX trades near $2.97, with institutional peers like BlackRock adjusting their holdings.
- Analysts maintain a positive outlook on GNLX, with recent buy ratings and price targets up to $30.
Important disclosure: EarningsIQ is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
James Tyree, an insider, purchased 31,566 shares of GNLX on June 16, 2026. The transaction was not part of a pre-planned trading program. The stock was trading at around $2.97 at the time of the purchase.
Insider Buying and Selling at Genelux Corporation
Several insiders were active in GNLX on June 16, 2026. Alongside James Tyree, John Smither, Mary Mirabelli, and Yong Yu, the Chief Scientific Officer, each bought 31,566 shares. John Smither also made an additional purchase of 28,409 shares. These transactions were not executed under Rule 10b5-1 plans.
Other Institutional Activity in GNLX
Institutional investors are also adjusting their positions in GNLX. Woodward Diversified Capital, LLC increased its stake by 184,472 shares, bringing its total to 2,117,183 shares valued at approximately $5.91 million. Vanguard Capital Management LLC added 1,695,480 shares, now holding the same amount, worth about $4.10 million. Bleichroeder LP significantly boosted its holdings by 666,666 shares, for a total of 1,380,666 shares valued at $3.34 million. Geode Capital Management, LLC and BlackRock, Inc. also grew their stakes, while Bank of America Corp /DE/ trimmed its position by 12,156 shares.
Analysts Set New Price Targets
Analysts are optimistic about GNLX. On March 20, 2026, Benchmark maintained its buy rating with a $20 price target. Lake Street initiated coverage with a buy rating and a $16 target on October 21, 2025. HC Wainwright & Co. reiterated its buy rating with a $30 target on March 25, 2025. Overall, the consensus remains positive, with multiple firms suggesting buy ratings and price targets ranging from $8 to $30.
Bottom Line
James Tyree's recent purchase of GNLX shares highlights insider confidence in the company. While the stock trades at roughly $2.97, institutional investors and analysts also show interest, with varied activity and positive ratings. As always, remember that insider and institutional transactions are disclosed after the fact and may not reflect current positions.
Get Genelux Corporation alerts
New 13F filings, insider trades, and analyst moves on $GNLX, sent to your inbox. Free, and you can unsubscribe anytime.
Related Filing Alerts
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
S